CONCORD, Calif.--(BUSINESS WIRE)--
Cerus Corporation (NASDAQ:CERS) announced today that its third quarter
results will be released on Tuesday, October 29, 2013, after the close
of the stock market. The company will host a conference call and webcast
at 4:15 PM ET that afternoon, during which management will discuss the
Company’s financial results and provide a general business overview and
outlook.
To access the live webcast, please visit the Investor Relations page of
the Cerus website at http://www.cerus.com/ir.
Alternatively, you may access the live conference call by dialing
866-235-9006 (U.S.) or 631-291-4549 (international).
A replay will be available on the company’s website, or by dialing
855-859-2056 (U.S.) or 404-537-3406 (international) and entering
conference ID number 31979526. The replay will be available
approximately three hours after the call through November 11, 2013.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused in the field
of blood safety. The company’s INTERCEPT Blood System has been
demonstrated to inactivate a broad range of viruses, bacteria and
parasites that may be present in donated blood, including established
threats such as hepatitis B and C, HIV, West Nile virus and bacteria, as
well as emerging pathogens such as influenza, malaria and dengue. Cerus
currently markets and sells the INTERCEPT Blood System for both
platelets and plasma in Europe, the Commonwealth of Independent States,
the Middle East and selected countries in other regions around the
world. In the United States, Cerus is seeking regulatory approval of the
INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood
cell system is in clinical development. See http://www.cerus.com
for more information.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
Source: Cerus Corporation